Skip to main content
Figure 5 | Journal of Biomedical Science

Figure 5

From: Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia

Figure 5

Apoptosis rate in HL60 cells after treatment with 50 μM H 2 O 2 for 2 h. The apoptosis rate was dependent on the BDH2- knockdown efficiency: A) shRNA-BDH2-1 HL60; B) shRNA-BDH2-2 HL60; C) shRNA-BDH2-3 HL60; D) shRNA-BDH2-4 HL60; and E) shRNA control vector HL60; F) the apoptosis rate of each cell lines. Dark gray: late apoptosis bar; light gray bar: early apoptosis.

Back to article page

Journal of Biomedical Science

ISSN: 1423-0127